References
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature 2013;496:504–7.
- World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Geneva: WHO; 2009.
- Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 2010;12:90–100.
- Leo YS, Thein TL, Fisher DA, Low JG, Oh HM, Narayanan RL, et al. Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study. BMC Infect Dis 2011;11:123.
- Lee IK, Liu JW, Yang KD. Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am J Trop Med Hyg 2008;79:149–53.
- Lahiri M, Fisher D, Tambyah PA. Dengue mortality: reassessing the risks in transition countries. Trans R Soc Trop Med Hyg 2008;102:1011–6.
- Kuo MC, Lu PL, Chang JM, Lin MY, Tsai JJ, Chen YH, et al. Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol 2008;3:1350–6.
- Chua MN, Molanida R, de Guzman M, Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993;24:141–3.
- Montenegro D, Lacerda HR, Lira TM, Oliveira DS, Lima AA, Guimarães MJ, et al. Clinical and epidemiological aspects of the dengue epidemic in Recife, PE. Rev Soc Bras Med Trop 2006;39:9–13.
- Almas A, Parkash O, Akhter J. Clinical factors associated with mortality in dengue infection at a tertiary care center. Southeast Asian J Trop Med Public Health 2010;41:333–40.
- World Health Organization Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue hemorrhagic fever. 2nd ed. India: WHO SEARO; 2011.
- Srikiatkhachorn A, Rothman AL, Gibbons RV, Sittisombut N, Malasit P, Ennis FA, et al. Dengue—how best to classify it. Clin Infect Dis 2011;53:563–7.
- Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2005;2:1.
- Nimmannitya S. Clinical manifestations of dengue/yellow haemorrhagic fever. Monograph on dengue/dengue haemorrhagic fever. New Delhi: WHO SEARO; 1993 pp 48–61.
- Jatanasen S, Thongcharoen F. Dengue haemorrhagic fever in Southeast Asian countries. Monograph on dengue/dengue haemorrhagic fever. New Delhi: WHO SEARO; 1993 pp 23–30.
- Ooi EE, Goh KT, Chee Wang DN. Effect of increasing age on the trend of dengue and dengue hemorrhagic fever in Singapore. Int J Infect Dis 2003;7:231–2.
- Humayoun MA, Waseem T, Jawa AA, Hashmi MS, Akram J. Multiple dengue serotypes and high frequency of dengue hemorrhagic fever at two tertiary care hospitals in Lahore during the 2008 dengue virus outbreak in Punjab, Pakistan. Int J Infect Dis 2010;14:54–9.
- World Health Organization. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. Second edition. Geneva: WHO; 1997.
- Assir MZ, Jawa A, Ahmad HI. Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage. BMC Infect Dis 2012;12:240.
- Santos NQ, Azoubel AC, Lopes AA, Costa G, Bacellar A. Guillain–Barré syndrome in the course of dengue: case report. Arq Neuropsiquiatr 2004;62:144–6.
- Rigau-Perez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992–1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006;42:1241–6.
- Chalasani N, Patel K, Clark WS, Wilcox CM. The prevalence and significance of leukocytosis in upper gastrointestinal bleeding. Am J Med Sci 1998;315:233–6.
- Lum LC, Abdel-Latif Mel A, Goh AY, Chan PW, Lam SK. Preventive transfusion in dengue shock syndrome—is it necessary?J Pediatr 2003;143:682–4.
- Assir MZ, Kamran U, Ahmad HI, Bashir S, Mansoor H, Anees SB, et al. Effectiveness of platelet transfusion in dengue fever: a randomized controlled trial. Transfus Med Hemother 2013;40:362–8.